Your search for buprenorphine returned 202 results

Median monthly retention rate was 22.2% during January 2016 through April 2022.

Among patients experiencing precipitated withdrawal, all were discharged after symptoms resolved, with one self-directed discharge.

Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine

Maternal, neonatal outcomes similar to buprenorphine monotherapy

More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone

The resubmitted NDA was in response to a Complete Response Letter issued by the FDA in December 2021.

Buprenorphine (as HCl) 2mg, 8mg; sublingual tabs.

Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine

Yet, study shows buprenorphine is effective in protecting against overdose in this population

Despite increases in units per prescription, the amount of buprenorphine dispensed to Medicaid beneficiaries decreased early in the pandemic